The global Brain Pacemaker Market represents a rapidly expanding segment of the medical device industry, valued at USD 3.66 ...

Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to ...

Medtronic often finds novel ways to apply familiar technologies, like using the implantable electronic stimulation in pacemakers to address fecal incontinence and chronic pain.

The study results support the electrical efficacy and safety of a catheter-delivered, lumenless lead in traditional or alternate right atrium or right ventricle sites through 18 months post-implant.

Methods The two regional studies utilized a lumenless, bipolar, permanent pacing lead (SelectSecure™ lead model 3830, Medtronic, Inc.) (Fig. 1). This 4.1-Fr-diameter, active fixation, steroid ...

Minnesota CEOs crowded around the golden opening bell of the New York Stock Exchange on Thursday morning, not on Wall Street ...

The uptick in the historic period can be linked to an increased preference for home-based cardiac monitoring, an enhancement in the number of cardiac surgeries and implantations, a burgeoning demand ...

Here at the New York Valves meeting, hosted by the Cardiovascular Research Foundation, panelists mulled over the options: either transvenous lead extraction or entrapment ("jailing") of the lead by ...

The University has partnered with the Medtronic Foundation to combine stem cell and biomedical engineering research that might allow diseased hearts to heal through regeneration. The Academic Health ...

Naples Comprehensive Health (NCH) has successfully performed a groundbreaking cardiac resynchronization therapy (CRT) procedure.

Medtronic plc received U.S. FDA approval for its Omniasecure defibrillation lead for placement in the right ventricle to treat arrhythmias. Medtronic said the lead is the smallest made at 4.7 French ...

Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...